cbdMD (YCBD) EBIT (2016 - 2025)
Historic EBIT for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to -$286288.0.
- cbdMD's EBIT fell 23184.35% to -$286288.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.4 million, marking a year-over-year decrease of 114.56%. This contributed to the annual value of -$2.2 million for FY2025, which is 3477.16% up from last year.
- Per cbdMD's latest filing, its EBIT stood at -$286288.0 for Q4 2025, which was down 23184.35% from -$685816.0 recorded in Q3 2025.
- Over the past 5 years, cbdMD's EBIT peaked at -$86272.0 during Q4 2024, and registered a low of -$33.1 million during Q2 2022.
- Moreover, its 5-year median value for EBIT was -$1.7 million (2023), whereas its average is -$6.2 million.
- Per our database at Business Quant, cbdMD's EBIT crashed by 132874.11% in 2021 and then surged by 9791.97% in 2024.
- Over the past 5 years, cbdMD's EBIT (Quarter) stood at -$25.1 million in 2021, then skyrocketed by 83.91% to -$4.0 million in 2022, then skyrocketed by 73.66% to -$1.1 million in 2023, then surged by 91.91% to -$86272.0 in 2024, then crashed by 231.84% to -$286288.0 in 2025.
- Its EBIT stands at -$286288.0 for Q4 2025, versus -$685816.0 for Q3 2025 and -$904686.0 for Q2 2025.